- Home
- DYN vs FORM Comparison
DYN vs FORM Comparison
Compare DYN & FORM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYN
- FORM
- Stock Information
- Founded
- DYN 1984
- FORM 1993
- Country
- DYN United States
- FORM United States
- Employees
- DYN N/A
- FORM N/A
- Industry
- DYN Medicinal Chemicals and Botanical Products
- FORM Semiconductors
- Sector
- DYN Health Care
- FORM Technology
- Exchange
- DYN Nasdaq
- FORM Nasdaq
- Market Cap
- DYN 2.6B
- FORM 2.9B
- IPO Year
- DYN 2020
- FORM N/A
- Fundamental
- Price
- DYN $14.01
- FORM $35.38
- Analyst Decision
- DYN Strong Buy
- FORM Buy
- Analyst Count
- DYN 10
- FORM 8
- Target Price
- DYN $50.78
- FORM $48.00
- AVG Volume (30 Days)
- DYN 2.1M
- FORM 998.6K
- Earning Date
- DYN 03-04-2025
- FORM 02-05-2025
- Dividend Yield
- DYN N/A
- FORM N/A
- EPS Growth
- DYN N/A
- FORM N/A
- EPS
- DYN N/A
- FORM 0.89
- Revenue
- DYN N/A
- FORM $763,599,000.00
- Revenue This Year
- DYN N/A
- FORM $11.12
- Revenue Next Year
- DYN N/A
- FORM $6.31
- P/E Ratio
- DYN N/A
- FORM $39.75
- Revenue Growth
- DYN N/A
- FORM 15.16
- 52 Week Low
- DYN $13.07
- FORM $32.71
- 52 Week High
- DYN $47.45
- FORM $63.63
- Technical
- Relative Strength Index (RSI)
- DYN 37.85
- FORM 35.70
- Support Level
- DYN $13.59
- FORM $36.68
- Resistance Level
- DYN $14.50
- FORM $38.93
- Average True Range (ATR)
- DYN 0.98
- FORM 2.04
- MACD
- DYN 0.32
- FORM 0.02
- Stochastic Oscillator
- DYN 22.90
- FORM 30.10
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases. The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. The company's product candidates are DYNE-101 and DYNE-251, both are in the ongoing phase 1/2 clinical trial.
About FORM FormFactor Inc. FormFactor Inc.
FormFactor Inc designs, develops, manufactures, sells, and supports semiconductor probe card products. The company operates in two reportable segments namely Probe Cards Segment and the Systems Segment. Sales of probe cards and analytical probes are included in the Probe Cards Segment, while sales of probe stations and thermal sub-systems are included in the Systems Segment. Probe cards generate the maximum revenue from its operations. It offers multiple product lines which include analytical probes, probe stations, thermal sub-systems, and related services.